Kidney Disease in the Cardiac Catheterization Laboratory

This book is the first title that focuses exclusively on kidney disease and its impact in the cardiac catheterization laboratory. The increasing prevalence of vascular risk factors such as diabetes, obesity and hypertension coupled with increased longevity has resulted in a worldwide epidemic of cardiovascular and chronic kidney disease (CKD).  Never has the impact of one organ system on the other been so profound, as in the current context of  cardio-renal interactions. The cross talk between the heart and kidneys is highly relevant in the field of  interventional cardiology, given the increasing number of trans-catheter procedures being performed in patients with underlying kidney disease. These procedures also have a  significant impact on kidney function and require thoughtful interdisciplinary planning by a cardiorenal team, to achieve optimal outcomes 

This book assembles the collective expertise of several  international leaders in the field of interventional cardiology and nephrology to summarize this complex interface. The book is divided into seven sections to comprehensively cover the topic, including sections on best practices with reduction of contrast associated acute kidney injury, cutting edge techniques to minimize kidney risk with complex interventions, impact of transcatheter valvular procedures on kidney function and the utility of cardio-nephrology teams . Less recognized  complications with high morbidity such as athero-embolic renal disease are  featured prominently, to increase awareness in the interventional cardiology and nephrology communities. 

This book is a valuable resource for interventional and structural cardiologists, general cardiologists and nephrologists dealing with the significant overlap areas between these two specialties. It is also relevant to medical students, trainee physicians in nephrology and cardiology, advanced care practitioners and nursing personnel in both specialties . Given the major impact of kidney function on outcomes in patients undergoing cardiac procedures, this  textbook serves as a focal point to integrate relevant clinical data from both specialties and help interventional cardiologists achieve optimal outcomes, especially in patients with (or at risk for) kidney disease. 

• Kidney Disease
• Cardiac Catheterization
• Atherosclerotic Cardiovascular Disease
• revascularization in Chronic Kidney Disease
• Acute Kidney Injury
• Reno-vascular interventions
• Medical Economics

• Einstein Medical Center/Thomas Jefferson University, Department of Medicine/Nephrology, Philadelphia, USA

  Janani Rangaswami

• UIC/Advocate Christ Medical Center, Department of Medicine, Chicago, Il, USA

  Edgar V. Lerma

• Baylor University Medical Center, Baylor Heart and Vascular Hospital, Department of Internal Medicine, Texas A & M College of Medicine, Division of Cardiology, Dallas, USA

  Peter A. McCullough

Janani Rangaswami, MD

Clinical Associate Professor

Einstein Medical Center / Thomas Jefferson University

Department of Medicine / Nephrology

Philadelphia, PA, USA

Edgar V. Lerma, MD

Clinical Professor of Medicine

UIC/Advocate Christ Medical Center

Department of Medicine

Oak Lawn, IL, USA

Peter A. McCullough, MD, MPH

Consultant Cardiologists and Vice Chief of Internal Medicine

Baylor University Medical Center

Baylor Heart and Vascular Hospital

Department of Internal Medicine

Texas A & M College of Medicine

Division of Cardiology

Dallas, TX, USA

Policies and ethics